Table 4. Effect of Other Drugs on Voriconazole Levels
| Drug/Drug Class | Voriconazole Levels | Recommendations for voriconazole dose adjustments |
|
Rifampin/Rifabutin
(CYP450 Induction) |
Significantly
reduced
|
CONTRAINDICATED
|
|
Carbamazepine (Tegretol®) |
Likely
to result in significant reduction
|
CONTRAINDICATED
|
|
Long-acting
barbiturates
(CYP450 Induction) |
Likely
to result in significant reduction
|
CONTRAINDICATED
|
|
Phenytoin
(Dilantin®)
(CYP450 Induction) |
Significantly
reduced
|
Increase
maintenance dose to 5mg/kg IV Q 12 hrs or
400 mg PO Q 12 hrs (If < 40 kg; 200 mg PO Q 12 hrs) |
|
HIV
Protease Inhibitors (PIs)
(CYP450 Induction) |
In-vivo studies showed no effect of indinavir (Crixivan®) on voriconazole; In-vitro studies show potential for interaction |
No dose adjustment needed with indinavir. Monitor for adverse effects or toxicity when given with other PIs. |
|
Non-nucleoside reverse
transcriptase inhibitors (NNRTIs) |
Potential
for inhibition or induction exists
|
Monitor
for adverse effects and toxicity of voriconazole or monitor for clinical
efficacy of voriconazole
|
Click Here to Return to Article